End Stage Renal Disease (ESRD) Center

Spotlights

Medicare Part B Immunosuppressive Drug (Part B-ID) - Patients who meet certain criteria will be able to qualify for continuous Medicare-covered immunosuppressive drugs after a kidney transplant
CMS-1749-P - CY 2022 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment System and Quality Incentive Program
8. ESRD Facility Conditions for Coverage (PDF)
FAQs ESRD Rollout FINAL 082808 (PDF)
FY 2016 Preview Period Extended until 8/31 2015 (PDF)

Important Links

Subscribe now to get the weekly MLN Connects® newsletter for the latest Fee-for-Service program information, event announcements, claims and pricer information, and MLN educational resources.